Beatrice Goilav

Profile image for Beatrice Goilav

Beatrice Goilav, MD

Pediatric Nephrology



  • Director, Pediatric Nephrology Training Program, Children's Hospital at Montefiore
  • Associate Professor of Pediatrics, Albert Einstein College of Medicine

The Children's Hospital at Montefiore
3415 Bainbridge Avenue
Bronx, NY 10467-2403
Directions

Montefiore Einstein
Children's Hospital at Montefiore

About

Researcher or Academic Professional?

View Faculty Profile

Click here to learn more about this specialist's research and educational efforts at the Albert Einstein College of Medicine.

Dr. Goilav is a pediatric nephrologist who is board certified in Pediatrics and Pediatric Nephrology. Her research interest is in lupus nephritis. She is currently doing translational research studying the role of very small interfering RNAs, called microRNAs, in the development and progression of lupus nephritis and their detection in human urine samples, as well as their role as biomarkers of disease activity.

Dr. Goilav graduated from the Faculty of Medicine, University of Basel, Switzerland, and did her internship and residency in pediatrics at Jacobi Medical Center. She completed her fellowship in pediatric nephrology at Mount Sinai School of Medicine. Dr. Goilav speaks German, Italian, Spanish, French, Hebrew, and Romanian.


Gender: Female

Languages

  • German
  • Italian
  • Spanish
  • French

Credentials

Titles and Positions

  • Director, Pediatric Nephrology Training Program, Children's Hospital at Montefiore
  • Associate Professor of Pediatrics, Albert Einstein College of Medicine

Education and Training

  • Medical Education University of Basel Medical School
  • Fellowship Mount Sinai Hospital
  • Residency Jacobi Medical Center
  • Residency University Hospital of Basel

Areas of Expertise

Specialties

  • Pediatric Nephrology

Clinical Focus

Polycystic kidney disease; lupus nephritis; biomarkers of acute kidney injury

Research Focus

The role of microRNAs in the development of lupus nephritis and their role in the modulation of the expression of neutrophil gelatinase-associated lipocalin (NGAL) and as urinary biomarkers of disease activity